1 |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2 |
Smyth EC, Lagergren J, Fitzgerald RC, et al. Oesophageal cancer[J]. Nat Rev Dis Primers, 2017, 3: 17048-57.
|
3 |
Burki TK. Definitions of oesophageal cancer[J]. Lancet Oncol, 2017, 18(2): e71-9.
|
4 |
Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(6): 432-43.
|
5 |
Shah MA, Kennedy EB, Catenacci DV, et al. Treatment of locally advanced esophageal carcinoma: ASCO guideline[J]. J Clin Oncol, 2020, 38(23): 2677-94.
|
6 |
O’Brien-Simpson NM, Veith PD, Dashper SG, et al. Antigens of bacteria associated with periodontitis[J]. Periodontol 2000, 2004, 35: 101-34.
|
7 |
Nakayama K, Yoshimura F, Kadowaki T, et al. Involvement of arginine-specific cysteine proteinase (arg-gingipain) in fimbriation of Porphyromonas gingivalis [J]. J Bacteriol, 1996, 178(10): 2818-24.
|
8 |
Genco CA, van Dyke T, Amar S. Animal models for Porphyromonas gingivalis-mediated periodontal disease[J]. Trends Microbiol, 1998, 6(11): 444-9.
|
9 |
Xu WZ, Zhou W, Wang HZ, et al. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis[J]. Adv Protein Chem Struct Biol, 2020, 120: 45-84.
|
10 |
Kadowaki T, Nakayama K, Okamoto K, et al. Porphyromonas gingivalis proteinases as virulence determinants in progression of periodontal diseases[J]. J Biochem, 2000, 128(2): 153-9.
|
11 |
Chen WA, Dou YT, Fletcher HM, et al. Local and systemic effects of Porphyromonas gingivalis infection[J]. Microorganisms, 2023, 11(2): 470-8.
|
12 |
Kadowaki T. Enzymatic characteristics and activities of gingipains from Porphyromonas gingivalis [J]. Methods Mol Biol, 2021, 2210: 97-112.
|
13 |
Gao SG, Li SG, Ma ZK, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer[J]. Infect Agent Cancer, 2016, 11: 3-15.
|
14 |
Ableser MJ, Penuela S, Lee J, et al. Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in vivo [J]. J Biol Chem, 2014, 289(3): 1592-603.
|
15 |
王丽娟, 李 静, 耿美玉. 间隙连接分子Cx43相关蛋白及其功能研究进展[J]. 现代生物医学进展, 2008, 8(10): 1967-71.
|
16 |
Totland MZ, Bergsland CH, Fykerud TA, et al. The E3 ubiquitin ligase NEDD4 induces endocytosis and lysosomal sorting of connexin 43 to promote loss of gap junctions[J]. J Cell Sci, 2017, 130(17): 2867-82.
|
17 |
Solan JL, Lampe PD. Specific Cx43 phosphorylation events regulate gap junction turnover in vivo [J]. FEBS Lett, 2014, 588(8): 1423-9.
|
18 |
Bigelow K, Nguyen TA. Increase of gap junction activities in SW480 human colorectal cancer cells[J]. BMC Cancer, 2014, 14: 502.
|
19 |
Tang B, Peng ZH, Yu PW, et al. Aberrant expression of Cx43 is associated with the peritoneal metastasis of gastric cancer and Cx43-mediated gap junction enhances gastric cancer cell diapedesis from peritoneal mesothelium[J]. PLoS One, 2013, 8(9): e74527.
|
20 |
Garber SA, Fernstrom MJ, Stoner GD, et al. Altered gap junctional intercellular communication in neoplastic rat esophageal epithelial cells[J]. Carcinogenesis, 1997, 18(6): 1149-53.
|
21 |
Tanaka T, Kimura M, Ishiguro H, et al. Connexin 43 expression is associated with poor survival in patients with esophageal squamous cell carcinoma[J]. Mol Clin Oncol, 2016, 4(6): 989-93.
|
22 |
Picardo SL, Coburn B, Hansen AR. The microbiome and cancer for clinicians[J]. Crit Rev Oncol Hematol, 2019, 141: 1-12.
|
23 |
Ding BB, Zhang GY, Yang XD, et al. Phosphoprotein of human parainfluenza virus type 3 blocks autophagosome-lysosome fusion to increase virus production[J]. Cell Host Microbe, 2014, 15(5): 564-77.
|
24 |
Shiheido-Watanabe Y, Maejima Y, Nakagama S, et al. Porphyromonas gingivalis, a periodontal pathogen, impairs post-infarcted myocardium by inhibiting autophagosome-lysosome fusion[J]. Int J Oral Sci, 2023, 15(1): 42.
|
25 |
Gao SG, Liu YW, Duan XX, et al. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy[J]. Br J Cancer, 2021, 125(3): 433-44.
|
26 |
Johnston CD, Bullman S. Bacteria-derived L-lactate fuels cervical cancer chemoradiotherapy resistance[J]. Trends Cancer, 2024, 10(2): 97-9.
|
27 |
Amanati A, Sajedianfard S, Khajeh S, et al. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance[J]. BMC Infect Dis, 2021, 21(1): 636.
|